Clinical Research and Pharmacogenetics

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Research

Pharmacogenetics

Inside The Altascientist: Understanding Drug Interaction Factors for Safer, More Effective Therapies

Alta Sciences

DECEMBER 31, 2024

One of the most important factors to consider during the course of your early-phase clinical research is drug-drug interactions (DDIs), which occurs when one drug alters the effect of another, either by reducing its effectiveness or elevating systemic concentrations to potentially dangerous levelsultimately causing side effects.

Therapies

Therapies Pharmacokinetics Pharmacogenetics Clinical Trials

Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel

The Pharma Data

OCTOBER 27, 2020

The system is a highly sensitive, cost-effective, mass spectrometry-based platform for high-throughput genetic analysis and is used globally in diverse research fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research.

Pharmacogenetics

Pharmacogenetics Laboratories Clinical Research FDA

Drug Discovery Digest

Inside The Altascientist: Understanding Drug Interaction Factors for Safer, More Effective Therapies

Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel

Stay Connected